Mackay Shields LLC Amgen Inc Transaction History

Mackay Shields LLC

$581 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $18.8 Million - $20.9 Million	-81,415 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $698,155 - $772,342	-3,184 Reduced 3.76%	81,415 $19.7 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $517,883 - $592,670	-2,604 Reduced 2.99%	84,599 $19 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $769,903 - $902,034	-3,627 Reduced 3.99%	87,203 $18.5 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $15.8 Million - $17.5 Million	-67,645 Reduced 42.68%	90,830 $22.1 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $14.9 Million - $17.4 Million	-67,256 Reduced 29.79%	158,475 $39.4 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $9.77 Million - $11.6 Million	45,152 Added 25.0%	225,731 $51.9 Million
Q3 2020 Nov 04, 2020	SELL	$234.65 - $260.95 $6.8 Million - $7.56 Million	-28,987 Reduced 13.83%	180,579 $45.9 Million
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $4.79 Million - $5.88 Million	-24,227 Reduced 10.36%	209,566 $49.4 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $4.25 Million - $5.64 Million	-23,328 Reduced 9.07%	233,793 $47.4 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $13 Million - $16.7 Million	68,849 Added 36.57%	257,121 $62 Million
Q3 2019 Nov 01, 2019	SELL	$174.11 - $208.62 $6.1 Million - $7.31 Million	-35,060 Reduced 15.7%	188,272 $36.4 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $12.8 Million - $15 Million	-76,854 Reduced 25.6%	223,332 $41.2 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $1.21 Million - $1.37 Million	-6,702 Reduced 2.18%	300,186 $57 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $54.7 Million - $63.9 Million	306,888 New	306,888 $59.7 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $41.6 Million - $46.9 Million	-224,463 Closed	0 $0
Q2 2018 Aug 06, 2018	SELL	$166.05 - $186.51 $206,566 - $232,018	-1,244 Reduced 0.55%	224,463 $41.4 Million
Q1 2018 May 03, 2018	BUY	$169.43 - $198.0 $38.2 Million - $44.7 Million	225,707 New	225,707 $38.5 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Account